The latest quarterly R&D expense is $13.84 Million with a QoQ Growth of -6.35%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $13.84M.
$13.84M
$13.84 Million
Q2 FY2026 · 2026-06-30
-6.35%
vs. $14.78M prior quarter
20
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $13.84M | -6.35% | -14.45% |
| Q1 FY2026Period end 2026-03-31 | $14.78M | -1.75% | -4.09% |
| Q4 FY2025Period end 2025-12-31 | $15.05M | +10.24% | -17.90% |
| Q3 FY2025Period end 2025-09-30 | $13.65M | -15.66% | -27.65% |
| Q2 FY2025Period end 2025-06-30 | $16.18M | +4.98% | +7.70% |
| Q1 FY2025Period end 2025-03-31 | $15.41M | -15.89% | +37.03% |
| Q4 FY2024Period end 2024-12-31 | $18.33M | -2.85% | +19.56% |
| Q3 FY2024Period end 2024-09-30 | $18.86M | +25.55% | +83.73% |
| Q2 FY2024Period end 2024-06-30 | $15.03M | +33.57% | +42.81% |
| Q1 FY2024Period end 2024-03-31 | $11.25M | -26.62% | +15.28% |
| Q4 FY2023Period end 2023-12-31 | $15.33M | +49.30% | +161.50% |
| Q3 FY2023Period end 2023-09-30 | $10.27M | -2.41% | +29.27% |
| Q2 FY2023Period end 2023-06-30 | $10.52M | +7.82% | +158.06% |
| Q1 FY2023Period end 2023-03-31 | $9.76M | +66.46% | +62.01% |
| Q4 FY2022Period end 2022-12-31 | $5.86M | -26.19% | +92.01% |
| Q3 FY2022Period end 2022-09-30 | $7.94M | +94.80% | +258.39% |
| Q2 FY2022Period end 2022-06-30 | $4.08M | -32.31% | N/A |
| Q1 FY2022Period end 2022-03-31 | $6.02M | +97.28% | N/A |
| Q4 FY2021Period end 2021-12-31 | $3.05M | +37.77% | N/A |
| Q3 FY2021Period end 2021-09-30 | $2.22M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
